NCT06525740 2026-03-04
Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery
Mayo Clinic
Phase 4 Recruiting
Clinical Trials
8 trialsNCT07315022 2026-01-02
Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University
Phase 4 Completed
NCT04296305 2025-12-26
Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain
M.D. Anderson Cancer Center
Phase 4 Active not recruiting
NCT05848635 2023-05-08
Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled
Qianfoshan Hospital
Phase 4 Unknown
NCT01812759 2021-06-29
Fentanyl for Breakthrough Pain in the Emergency Department
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT02459964 2021-06-16
Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain
M.D. Anderson Cancer Center
Phase 4 Completed
NCT02958566 2017-03-20
Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery
University of Illinois College of Medicine at Peoria
Phase 4 Unknown
NCT01648699 2013-10-11
Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain
Janssen Pharmaceutica
Phase 4 Terminated